"Risk factors for ventilator-associated pneumonia following cardiac surgery: case-control study".

[1]  A. Gurses,et al.  Reducing Three Infections Across Cardiac Surgery Programs: A Multisite Cross-Unit Collaboration , 2020, American journal of medical quality : the official journal of the American College of Medical Quality.

[2]  G. Whitman,et al.  Increased Glucose Variability Is Associated With Major Adverse Events After Coronary Artery Bypass. , 2019, The Annals of thoracic surgery.

[3]  J. Duchesne,et al.  Ventilator-Associated Pneumonia: How Do the Different Criteria for Diagnosis Match Up? , 2019, The American surgeon.

[4]  Deepak L. Bhatt,et al.  Restrictive versus liberal red blood cell transfusion for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials , 2018, Journal of Thrombosis and Thrombolysis.

[5]  H. Luckraz,et al.  Cost of treating ventilator-associated pneumonia post cardiac surgery in the National Health Service: Results from a propensity-matched cohort study , 2018, Journal of the Intensive Care Society.

[6]  J. Lucet,et al.  Infection prevention and control measures and tools for the prevention of entry of carbapenem-resistant Enterobacteriaceae into healthcare settings: guidance from the European Centre for Disease Prevention and Control , 2017, Antimicrobial Resistance & Infection Control.

[7]  S. Bagshaw,et al.  Restrictive or Liberal Red‐Cell Transfusion for Cardiac Surgery , 2017, The New England journal of medicine.

[8]  J. Claridge,et al.  Current Pneumonia Surveillance Methodology: Similar Underestimation in Trauma and Surgical Patients in the Intensive Care Unit. , 2017, Surgical infections.

[9]  A. Moskowitz,et al.  Pneumonia after cardiac surgery: Experience of the National Institutes of Health/Canadian Institutes of Health Research Cardiothoracic Surgical Trials Network , 2017, The Journal of thoracic and cardiovascular surgery.

[10]  B. Cairns,et al.  From VAP to VAE: Implications of the New CDC Definitions on a Burn Intensive Care Unit Population , 2017, Infection Control & Hospital Epidemiology.

[11]  G. Umpierrez,et al.  Hospitalization costs and clinical outcomes in CABG patients treated with intensive insulin therapy. , 2017, Journal of diabetes and its complications.

[12]  Peggy Cruse,et al.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  G. Umpierrez,et al.  Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial , 2015, Diabetes Care.

[14]  Chih-Cheng Lai,et al.  Differences between novel and conventional surveillance paradigms of ventilator-associated pneumonia. , 2015, American journal of infection control.

[15]  Wei Li,et al.  Ventilator-associated pneumonia after cardiac surgery: a meta-analysis and systematic review. , 2014, The Journal of thoracic and cardiovascular surgery.

[16]  Antonio Gasparrini,et al.  Conditional Poisson models: a flexible alternative to conditional logistic case cross-over analysis , 2014, BMC Medical Research Methodology.

[17]  C. Lilly,et al.  Prevalence and Test Characteristics of National Health Safety Network Ventilator-Associated Events , 2014, Critical care medicine.

[18]  Q. Xing,et al.  Independent Risk Factors for Ventilator-Associated Pneumonia After Cardiac Surgery , 2014, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[19]  S. Berenholtz,et al.  Strategies to Prevent Ventilator-Associated Pneumonia in Acute Care Hospitals: 2014 Update , 2014, Infection Control & Hospital Epidemiology.

[20]  Rolf H H Groenwold,et al.  Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies. , 2013, The Lancet. Infectious diseases.

[21]  M. Acker,et al.  Blood transfusion and infection after cardiac surgery. , 2013, The Annals of thoracic surgery.

[22]  J. Eiros,et al.  Ventilator-associated pneumonia is an important risk factor for mortality after major cardiac surgery. , 2012, Journal of critical care.

[23]  L. Henry,et al.  Strict versus liberal target range for perioperative glucose in patients undergoing coronary artery bypass grafting: a prospective randomized controlled trial. , 2012, The Journal of thoracic and cardiovascular surgery.

[24]  Samer A M Nashef,et al.  EuroSCORE II. , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  S. Levidiotou,et al.  Are there independent predisposing factors for postoperative infections following open heart surgery? , 2011, Journal of cardiothoracic surgery.

[26]  T. Mihaljevic,et al.  Transfusion and pulmonary morbidity after cardiac surgery. , 2009, The Annals of thoracic surgery.

[27]  M. Desco,et al.  Incidence and risk factors for ventilator-associated pneumonia after major heart surgery , 2009 .

[28]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[29]  E. Bouza,et al.  Ventilator-associated pneumonia after heart surgery: A prospective analysis and the value of surveillance* , 2003, Critical care medicine.

[30]  J. Llorca,et al.  Nosocomial infections in patients having cardiovascular operations: a multivariate analysis of risk factors. , 1996, The Journal of thoracic and cardiovascular surgery.

[31]  J K McLaughlin,et al.  Selection of controls in case-control studies. II. Types of controls. , 1992, American journal of epidemiology.